Tumor suppressor maspin as a modulator of host immune response to cancer
Despite the promising clinical outcome, the primary challenge of the curative cancer immunotherapy is to overcome the dichotomy of the immune response: tumor-evoked immunostimulatory versus tumor-induced immunosuppressive. The goal needs to be two-fold, to re-establish sustainable antitumor-cancer...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2015-10-01
|
Series: | Bosnian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | https://bjbms.org/ojs/index.php/bjbms/article/view/783 |